Diaceutics PLC (AIM:DXRX)

Market Cap	116.25M
Revenue (ttm)	32.16M
Net Income (ttm)	-1.70M
Shares Out	84.55M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	112.89
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62,976
Average Volume	237,219
Open	140.00
Previous Close	137.50
Day's Range	135.00 - 140.00
52-Week Range	106.00 - 151.00
Beta	0.73
RSI	74.24
Earnings Date	Sep 15, 2025

About Diaceutics

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 2005
• Employees: 199
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: DXRX

Financial Performance

In 2024, Diaceutics's revenue was 32.16 million, an increase of 35.69% compared to the previous year's 23.70 million. Losses were -1.70 million, -2.46% less than in 2023.